Global and Japan Nasal Flu Vaccine Market Insights, Forecast to 2027
SKU ID : QYR-19202517 | Publishing Date : 22-Sep-2021 | No. of pages : 123
Detailed TOC of Global and Japan Nasal Flu Vaccine Market Insights, Forecast to 2027
1 Study Coverage1.1 Nasal Flu Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Nasal Flu Vaccine Market Size Growth Rate by Type
1.2.2 Trivalent Flu Vaccine
1.2.3 Quadrivalent Flu Vaccine
1.3 Market by Application
1.3.1 Global Nasal Flu Vaccine Market Size Growth Rate by Application
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nasal Flu Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Nasal Flu Vaccine Revenue 2016-2027
2.1.2 Global Nasal Flu Vaccine Sales 2016-2027
2.2 Global Nasal Flu Vaccine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nasal Flu Vaccine Historical Market Size by Region (2016-2021)
2.3.1 Global Nasal Flu Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nasal Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nasal Flu Vaccine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nasal Flu Vaccine Sales Forecast by Region (2022-2027)
2.4.2 Global Nasal Flu Vaccine Revenue Forecast by Region (2022-2027)
3 Global Nasal Flu Vaccine Competitor Landscape by Players
3.1 Global Top Nasal Flu Vaccine Manufacturers by Sales
3.1.1 Global Nasal Flu Vaccine Sales by Manufacturer (2016-2021)
3.1.2 Global Nasal Flu Vaccine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nasal Flu Vaccine Manufacturers by Revenue
3.2.1 Key Nasal Flu Vaccine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nasal Flu Vaccine Revenue by Manufacturers (2016-2021)
3.2.3 Global Nasal Flu Vaccine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nasal Flu Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nasal Flu Vaccine Revenue in 2020
3.2.6 Global Nasal Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nasal Flu Vaccine Price by Manufacturers
3.4 Global Nasal Flu Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Nasal Flu Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nasal Flu Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Nasal Flu Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Nasal Flu Vaccine Market Size by Type (2016-2021)
4.1.1 Global Nasal Flu Vaccine Sales by Type (2016-2021)
4.1.2 Global Nasal Flu Vaccine Revenue by Type (2016-2021)
4.1.3 Nasal Flu Vaccine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nasal Flu Vaccine Market Size Forecast by Type (2022-2027)
4.2.1 Global Nasal Flu Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Nasal Flu Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Nasal Flu Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Nasal Flu Vaccine Market Size by Application (2016-2021)
5.1.1 Global Nasal Flu Vaccine Sales by Application (2016-2021)
5.1.2 Global Nasal Flu Vaccine Revenue by Application (2016-2021)
5.1.3 Nasal Flu Vaccine Price by Application (2016-2021)
5.2 Nasal Flu Vaccine Market Size Forecast by Application (2022-2027)
5.2.1 Global Nasal Flu Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Nasal Flu Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Nasal Flu Vaccine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Nasal Flu Vaccine Market Size YoY Growth 2016-2027
6.1.1 Japan Nasal Flu Vaccine Sales YoY Growth 2016-2027
6.1.2 Japan Nasal Flu Vaccine Revenue YoY Growth 2016-2027
6.1.3 Japan Nasal Flu Vaccine Market Share in Global Market 2016-2027
6.2 Japan Nasal Flu Vaccine Market Size by Players (International and Local Players)
6.2.1 Japan Top Nasal Flu Vaccine Players by Sales (2016-2021)
6.2.2 Japan Top Nasal Flu Vaccine Players by Revenue (2016-2021)
6.3 Japan Nasal Flu Vaccine Historic Market Review by Type (2016-2021)
6.3.1 Japan Nasal Flu Vaccine Sales Market Share by Type (2016-2021)
6.3.2 Japan Nasal Flu Vaccine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Nasal Flu Vaccine Price by Type (2016-2021)
6.4 Japan Nasal Flu Vaccine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Nasal Flu Vaccine Sales Forecast by Type (2022-2027)
6.4.2 Japan Nasal Flu Vaccine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Nasal Flu Vaccine Price Forecast by Type (2022-2027)
6.5 Japan Nasal Flu Vaccine Historic Market Review by Application (2016-2021)
6.5.1 Japan Nasal Flu Vaccine Sales Market Share by Application (2016-2021)
6.5.2 Japan Nasal Flu Vaccine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Nasal Flu Vaccine Price by Application (2016-2021)
6.6 Japan Nasal Flu Vaccine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Nasal Flu Vaccine Sales Forecast by Application (2022-2027)
6.6.2 Japan Nasal Flu Vaccine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Nasal Flu Vaccine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Nasal Flu Vaccine Market Size YoY Growth 2016-2027
7.2 North America Nasal Flu Vaccine Market Facts & Figures by Country
7.2.1 North America Nasal Flu Vaccine Sales by Country (2016-2021)
7.2.2 North America Nasal Flu Vaccine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Nasal Flu Vaccine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nasal Flu Vaccine Market Facts & Figures by Region
8.2.1 Asia Pacific Nasal Flu Vaccine Sales by Region (2016-2021)
8.2.2 Asia Pacific Nasal Flu Vaccine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Nasal Flu Vaccine Market Size YoY Growth 2016-2027
9.2 Europe Nasal Flu Vaccine Market Facts & Figures by Country
9.2.1 Europe Nasal Flu Vaccine Sales by Country (2016-2021)
9.2.2 Europe Nasal Flu Vaccine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Nasal Flu Vaccine Market Size YoY Growth 2016-2027
10.2 Latin America Nasal Flu Vaccine Market Facts & Figures by Country
10.2.1 Latin America Nasal Flu Vaccine Sales by Country (2016-2021)
10.2.2 Latin America Nasal Flu Vaccine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Nasal Flu Vaccine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nasal Flu Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Nasal Flu Vaccine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nasal Flu Vaccine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Nasal Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Nasal Flu Vaccine Products Offered
12.1.5 AstraZeneca Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Nasal Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Nasal Flu Vaccine Products Offered
12.11.5 AstraZeneca Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nasal Flu Vaccine Industry Trends
13.2 Nasal Flu Vaccine Market Drivers
13.3 Nasal Flu Vaccine Market Challenges
13.4 Nasal Flu Vaccine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nasal Flu Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Nasal Flu Vaccine Market Insights, Forecast to 2027
List of TablesTable 1. Global Nasal Flu Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Trivalent Flu Vaccine
Table 3. Major Manufacturers of Quadrivalent Flu Vaccine
Table 4. Global Nasal Flu Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Nasal Flu Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Nasal Flu Vaccine Sales by Regions (2016-2021) & (K Units)
Table 7. Global Nasal Flu Vaccine Sales Market Share by Regions (2016-2021)
Table 8. Global Nasal Flu Vaccine Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Nasal Flu Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Nasal Flu Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Nasal Flu Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Nasal Flu Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Nasal Flu Vaccine Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Nasal Flu Vaccine Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Nasal Flu Vaccine Manufacturers by Revenue (US$ Million) in 2020
Table 16. Nasal Flu Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Nasal Flu Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Global Nasal Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Nasal Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nasal Flu Vaccine as of 2020)
Table 20. Key Manufacturers Nasal Flu Vaccine Price (2016-2021) (US$/Unit)
Table 21. Nasal Flu Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nasal Flu Vaccine Product Type
Table 23. Date of International Manufacturers Enter into Nasal Flu Vaccine Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Nasal Flu Vaccine Sales by Type (2016-2021) (K Units)
Table 26. Global Nasal Flu Vaccine Sales Share by Type (2016-2021)
Table 27. Global Nasal Flu Vaccine Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Nasal Flu Vaccine Revenue Share by Type (2016-2021)
Table 29. Nasal Flu Vaccine Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Nasal Flu Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Nasal Flu Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Nasal Flu Vaccine Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Nasal Flu Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Nasal Flu Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Nasal Flu Vaccine Sales by Application (2016-2021) (K Units)
Table 36. Global Nasal Flu Vaccine Sales Share by Application (2016-2021)
Table 37. Global Nasal Flu Vaccine Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Nasal Flu Vaccine Revenue Share by Application (2016-2021)
Table 39. Nasal Flu Vaccine Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Nasal Flu Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Nasal Flu Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Nasal Flu Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Nasal Flu Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Nasal Flu Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. Japan Nasal Flu Vaccine Sales (K Units) of Key Companies (2016-2021)
Table 46. Japan Nasal Flu Vaccine Sales Share by Company (2016-2021)
Table 47. Japan Nasal Flu Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Nasal Flu Vaccine Revenue Share by Company (2016-2021)
Table 49. Japan Nasal Flu Vaccine Sales (K Units) by Type (2016-2021)
Table 50. Japan Nasal Flu Vaccine Sales Share by Type (2016-2021)
Table 51. Japan Nasal Flu Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Nasal Flu Vaccine Price (US$/Unit) by Type (2016-2021)
Table 53. Japan Nasal Flu Vaccine Sales (K Units) by Type (2022-2027)
Table 54. Japan Nasal Flu Vaccine Sales Share by Type (2022-2027)
Table 55. Japan Nasal Flu Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Nasal Flu Vaccine Revenue Share by Type (2022-2027)
Table 57. Japan Nasal Flu Vaccine Price (US$/Unit) by Type (2022-2027)
Table 58. Japan Nasal Flu Vaccine Sales (K Units) by Application (2016-2021)
Table 59. Japan Nasal Flu Vaccine Sales Share by Application (2016-2021)
Table 60. Japan Nasal Flu Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Nasal Flu Vaccine Price (US$/Unit) by Application (2016-2021)
Table 62. Japan Nasal Flu Vaccine Sales (K Units) by Application (2022-2027)
Table 63. Japan Nasal Flu Vaccine Sales Share by Application (2022-2027)
Table 64. Japan Nasal Flu Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Nasal Flu Vaccine Revenue Share by Application (2022-2027)
Table 66. Japan Nasal Flu Vaccine Price (US$/Unit) by Application (2022-2027)
Table 67. North America Nasal Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 68. North America Nasal Flu Vaccine Sales Market Share by Country (2016-2021)
Table 69. North America Nasal Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Nasal Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Nasal Flu Vaccine Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Nasal Flu Vaccine Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Nasal Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Nasal Flu Vaccine Revenue Market Share by Region (2016-2021)
Table 75. Europe Nasal Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 76. Europe Nasal Flu Vaccine Sales Market Share by Country (2016-2021)
Table 77. Europe Nasal Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Nasal Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 79. Latin America Nasal Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Nasal Flu Vaccine Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Nasal Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Nasal Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Nasal Flu Vaccine Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Nasal Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Country (2016-2021)
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Nasal Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. AstraZeneca Nasal Flu Vaccine Product
Table 91. AstraZeneca Recent Development
Table 92. Nasal Flu Vaccine Market Trends
Table 93. Nasal Flu Vaccine Market Drivers
Table 94. Nasal Flu Vaccine Market Challenges
Table 95. Nasal Flu Vaccine Market Restraints
Table 96. Nasal Flu Vaccine Customers List
Table 97. Nasal Flu Vaccine Distributors List
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Flu Vaccine Product Picture
Figure 2. Global Nasal Flu Vaccine Sales Market Share by Type in 2020 & 2027
Figure 3. Trivalent Flu Vaccine Product Picture
Figure 4. Quadrivalent Flu Vaccine Product Picture
Figure 5. Global Nasal Flu Vaccine Sales Market Share by Application in 2020 & 2027
Figure 6. Child
Figure 7. Adult
Figure 8. Nasal Flu Vaccine Report Years Considered
Figure 9. Global Nasal Flu Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Nasal Flu Vaccine Market Size 2016-2027 (US$ Million)
Figure 11. Global Nasal Flu Vaccine Sales 2016-2027 (K Units)
Figure 12. Global Nasal Flu Vaccine Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Nasal Flu Vaccine Sales Market Share by Region (2016-2021)
Figure 14. Global Nasal Flu Vaccine Sales Market Share by Region in 2020
Figure 15. Global Nasal Flu Vaccine Revenue Market Share by Region (2016-2021)
Figure 16. Global Nasal Flu Vaccine Revenue Market Share by Region in 2020
Figure 17. Global Nasal Flu Vaccine Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Nasal Flu Vaccine Revenue in 2020
Figure 19. Nasal Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Nasal Flu Vaccine Sales Market Share by Type (2016-2021)
Figure 21. Global Nasal Flu Vaccine Sales Market Share by Type in 2020
Figure 22. Global Nasal Flu Vaccine Revenue Market Share by Type (2016-2021)
Figure 23. Global Nasal Flu Vaccine Revenue Market Share by Type in 2020
Figure 24. Global Nasal Flu Vaccine Sales Market Share by Application (2016-2021)
Figure 25. Global Nasal Flu Vaccine Sales Market Share by Application in 2020
Figure 26. Global Nasal Flu Vaccine Revenue Market Share by Application (2016-2021)
Figure 27. Global Nasal Flu Vaccine Revenue Market Share by Application in 2020
Figure 28. Japan Nasal Flu Vaccine Sales Growth Rate 2016-2027 (K Units)
Figure 29. Japan Nasal Flu Vaccine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. Japan Nasal Flu Vaccine Market Share in Global Market 2016-2027
Figure 31. Japan 5 and 10 Largest Nasal Flu Vaccine Players Market Share by Revenue in Nasal Flu Vaccine in 2020
Figure 32. Japan Nasal Flu Vaccine Revenue Share by Type (2016-2021)
Figure 33. Japan Nasal Flu Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Japan Nasal Flu Vaccine Revenue Share by Application (2016-2021)
Figure 35. Japan Nasal Flu Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Nasal Flu Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 37. North America Nasal Flu Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Nasal Flu Vaccine Sales Market Share by Country in 2020
Figure 39. North America Nasal Flu Vaccine Revenue Market Share by Country in 2020
Figure 40. U.S. Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 41. U.S. Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 43. Canada Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Nasal Flu Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 45. Europe Nasal Flu Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Nasal Flu Vaccine Sales Market Share by Country in 2020
Figure 47. Europe Nasal Flu Vaccine Revenue Market Share by Country in 2020
Figure 48. Germany Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 49. Germany Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 51. France Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 53. U.K. Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 55. Italy Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 57. Russia Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Nasal Flu Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 59. Asia Pacific Nasal Flu Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Nasal Flu Vaccine Sales Market Share by Region in 2020
Figure 61. Asia Pacific Nasal Flu Vaccine Revenue Market Share by Region in 2020
Figure 62. China Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 63. China Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 65. Japan Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 67. South Korea Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 69. India Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 71. Australia Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 73. Taiwan Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 75. Indonesia Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 77. Thailand Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 79. Malaysia Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 81. Philippines Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 83. Vietnam Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Nasal Flu Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Nasal Flu Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Nasal Flu Vaccine Sales Market Share by Country in 2020
Figure 87. Latin America Nasal Flu Vaccine Revenue Market Share by Country in 2020
Figure 88. Mexico Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Nasal Flu Vaccine Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Nasal Flu Vaccine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Nasal Flu Vaccine Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Nasal Flu Vaccine Revenue Market Share by Country in 2020
Figure 98. Turkey Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Nasal Flu Vaccine Sales Growth Rate (2016-2021) (K Units)
Figure 103. UAE Nasal Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Nasal Flu Vaccine Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed